Search Results

There are 68252 results for: content related to: Bevacizumab: Finding its niche in the treatment of heart failure secondary to liver vascular malformations in hereditary hemorrhagic telangiectasia

  1. Hereditary hemorrhagic telangiectasia–related epistaxis: innovations in understanding and management

    International Forum of Allergy & Rhinology

    Volume 2, Issue 5, September/October 2012, Pages: 422–431, Nathan B. Sautter and Timothy L. Smith

    Version of Record online : 7 MAY 2012, DOI: 10.1002/alr.21046

  2. Bevacizumab in hereditary hemorrhagic telangiectasia-associated epistaxis: Effectiveness of an injection protocol based on the vascular anatomy of the nose

    The Laryngoscope

    Volume 122, Issue 6, June 2012, Pages: 1210–1214, Sinan Dheyauldeen, Amy Østertun Geirdal, Terje Osnes, Liv Sofie Vartdal and Ralph Dollner

    Version of Record online : 7 MAY 2012, DOI: 10.1002/lary.23303

  3. You have free access to this content
    How to manage patients with hereditary haemorrhagic telangiectasia

    British Journal of Haematology

    Volume 171, Issue 4, November 2015, Pages: 443–452, Urban W. Geisthoff, Ha-Long Nguyen, Alexander Röth and Ulrich Seyfert

    Version of Record online : 23 JUL 2015, DOI: 10.1111/bjh.13606

  4. Intravenous bevacizumab for complications of hereditary hemorrhagic telangiectasia: a review of the literature

    International Forum of Allergy & Rhinology

    Volume 5, Issue 11, November 2015, Pages: 1042–1047, Natalia P. Arizmendez, Luke Rudmik and David M. Poetker

    Version of Record online : 22 JUL 2015, DOI: 10.1002/alr.21587

  5. Intranasal submucosal bevacizumab for epistaxis in hereditary hemorrhagic telangiectasia: A double-blind, randomized, placebo-controlled trial

    Head & Neck

    Volume 37, Issue 6, June 2015, Pages: 783–787, Dominik Riss, Martin Burian, Axel Wolf, Veronika Kranebitter, Alexandra Kaider and Christoph Arnoldner

    Version of Record online : 30 APR 2014, DOI: 10.1002/hed.23655

  6. Hereditary haemorrhagic telangiectasia, an Australian cohort: clinical and investigative features

    Internal Medicine Journal

    Volume 44, Issue 7, July 2014, Pages: 639–644, M. Salaria, J. Taylor, M. Bogwitz and I. Winship

    Version of Record online : 7 JUL 2014, DOI: 10.1111/imj.12457

  7. Safety of intranasal Bevacizumab (avastin) treatment in patients with hereditary hemorrhagic telangiectasia-associated epistaxis

    The Laryngoscope

    Volume 121, Issue 3, March 2011, Pages: 644–646, Sonia Chen IV, Tom Karnezis and Terence M. Davidson

    Version of Record online : 11 NOV 2010, DOI: 10.1002/lary.21345

  8. Treatment of hereditary hemorrhagic telangiectasia with submucosal and topical bevacizumab therapy

    The Laryngoscope

    Volume 122, Issue 3, March 2012, Pages: 495–497, Tom T. Karnezis and Terence M. Davidson

    Version of Record online : 6 DEC 2011, DOI: 10.1002/lary.22501

  9. Hereditary hemorrhagic telangiectasia: to transplant or not to transplant?

    Liver International

    Volume 36, Issue 12, December 2016, Pages: 1741–1744, Sophie Dupuis-Girod and Elisabetta Buscarini

    Version of Record online : 19 NOV 2016, DOI: 10.1111/liv.13210

  10. Quality of life in patients with hereditary hemorrhagic telangiectasia in Norway: A population based study

    American Journal of Medical Genetics Part A

    Volume 158A, Issue 6, June 2012, Pages: 1269–1278, Amy Østertun Geirdal, Sinan Dheyauldeen, Gregor Bachmann-Harildstad and Ketil Heimdal

    Version of Record online : 23 APR 2012, DOI: 10.1002/ajmg.a.35309

  11. The effect of anterior palatine blocks on bleeding in hereditary hemorrhagic telangiectasia nasal surgery

    The Laryngoscope

    Volume 123, Issue 11, November 2013, Pages: 2598–2600, Carly C. Guthrie, Tom T. Karnezis, Ryan K. Orosco, Michael L. Bishop and Terence M. Davidson

    Version of Record online : 13 MAY 2013, DOI: 10.1002/lary.24076

  12. You have free access to this content
    Successful management of chronic gastrointestinal hemorrhage using bevacizumab in the setting of hereditary hemorrhagic telangiectasia

    American Journal of Hematology

    Volume 90, Issue 6, June 2015, Pages: 561–563, Mary E. Sehl, Theresa M. Gruber, Justin P. McWilliams and Victor J. Marder

    Version of Record online : 10 MAY 2015, DOI: 10.1002/ajh.23969

  13. Lifestyle and Dietary Influences on Nosebleed Severity in Hereditary Hemorrhagic Telangiectasia

    The Laryngoscope

    Volume 123, Issue 5, May 2013, Pages: 1092–1099, B. Maneesha Silva, Anna E. Hosman, Hannah L. Devlin and Claire L. Shovlin

    Version of Record online : 12 FEB 2013, DOI: 10.1002/lary.23893

  14. Efficacy of intranasal bevacizumab (Avastin) treatment in patients with hereditary hemorrhagic telangiectasia-associated epistaxis

    The Laryngoscope

    Volume 121, Issue 3, March 2011, Pages: 636–638, Tom T. Karnezis and Terence M. Davidson

    Version of Record online : 16 DEC 2010, DOI: 10.1002/lary.21415

  15. Osteonecrosis after intranasal injection with bevacizumab in treating hereditary hemorrhagic telangiectasia: A case report

    The Laryngoscope

    Johan Steineger, Else Merckoll, John Magnar Slåstad, Erik Fink Eriksen, Ketil Heimdal and Sinan Dheyauldeen

    Version of Record online : 3 JUL 2017, DOI: 10.1002/lary.26722

  16. The effect of bevacizumab (Avastin) treatment on epistaxis in hereditary hemorrhagic telangiectasia

    The Laryngoscope

    Volume 119, Issue 5, May 2009, Pages: 988–992, Jana Simonds, Frank Miller, Jess Mandel and Terence M. Davidson

    Version of Record online : 4 FEB 2009, DOI: 10.1002/lary.20159

  17. Relationships between epistaxis, migraines, and triggers in hereditary hemorrhagic telangiectasia

    The Laryngoscope

    Volume 124, Issue 7, July 2014, Pages: 1521–1528, Amy Elphick and Claire L. Shovlin

    Version of Record online : 23 JAN 2014, DOI: 10.1002/lary.24526

  18. Overlapping spectra of SMAD4 mutations in juvenile polyposis (JP) and JP–HHT syndrome

    American Journal of Medical Genetics Part A

    Volume 152A, Issue 2, February 2010, Pages: 333–339, Carol Gallione, Arthur S. Aylsworth, Jill Beis, Terri Berk, Barbara Bernhardt, Robin D. Clark, Carol Clericuzio, Cesare Danesino, Joanne Drautz, Jeffrey Fahl, Zheng Fan, Marie E. Faughnan, Arupa Ganguly, John Garvie, Katharine Henderson, Usha Kini, Tracey Leedom, Mark Ludman, Andreas Lux, Melissa Maisenbacher, Sara Mazzucco, Carla Olivieri, Johannes K. Ploos van Amstel, Nadia Prigoda-Lee, Reed E. Pyeritz, Willie Reardon, Kirk Vandezande, J. Deane Waldman, Robert I. White Jr., Charles A. Williams and Douglas A. Marchuk

    Version of Record online : 25 JAN 2010, DOI: 10.1002/ajmg.a.33206

  19. Complications from office sclerotherapy for epistaxis due to hereditary hemorrhagic telangiectasia (HHT or Osler-Weber-Rendu)

    International Forum of Allergy & Rhinology

    Volume 4, Issue 5, May 2014, Pages: 422–427, John E. Hanks, David Hunter, George S. Goding Jr and Holly C. Boyer

    Version of Record online : 15 JAN 2014, DOI: 10.1002/alr.21287

  20. National mutation study among Danish patients with hereditary haemorrhagic telangiectasia

    Clinical Genetics

    Volume 86, Issue 2, August 2014, Pages: 123–133, P.M. Tørring, K. Brusgaard, L.B. Ousager, P.E. Andersen and A.D. Kjeldsen

    Version of Record online : 3 OCT 2013, DOI: 10.1111/cge.12269